Neuron23
ID: 7378393Neuron23 is an AI-drug discovery founded in 2018 by Adam Knight.
3
Funding Rounds
$276.5m
Money raised
Recent Funding Rounds
Overview
Neuron23 is an AI-drug discovery founded in 2018 by Adam Knight.
- Website:
- Business model: B2B
- Social accounts: linkedin
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| Ad** Kn**** | - | - | - |
Funding
Funding series
Funding Series Analysis
The company Neuron23 has raised a total of $196.5m in funding over 3 rounds.
Key Insights:
- Neuron23 June 2025 Series D Funding Round: $96.5m
- Neuron23 Series C round: $100m
- Neuron23 Series B round December 2020: $80m
Industries
Neuron23 is active in the following industries: